Cancer Biomarkers: Players, products and prospects (Volume I)

Summary

Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cancer biomarker sector, along with a critical assessment of the companies involved.

Contents

• Executive Summary
  • Figure1: Growth In Biomarker Market 2007-2015
• What Are Biomarkers?
• Why Are They Important?
  • Figure 2: Potential Impact Of Biomarkers On Disease Pathways
• What Technologies Are Involved?
• What Impact Will Biomarkers Have On R&d?
  • Figure 3: Potential Impact Of Biomarkers On R&d
• Who Are The Major Biomarker Players And In What Research Area?
• Cancer Biomarker Companies
• Cardiovascular Biomarker Companies
• Cns Biomarkers Companies
• Company Analysis Criteria
• Biomarker Technology & Platforms
• Association/Clinical Studies
• Management Strategy
• Application & Potential
• Cancer Market & Revenues
  • Market Revenues - Global
    • Figure 1: Global Cancer Drugs Sales (2007)
  • Market Revenues - Leading Brands
    • Figure 2: Leading Cancer Brands (2007)
  • Market Revenues - Leading Players
    • Figure 3: Top 10 Oncology Players (2007 Revenues)
• Cancer Epidemiology, Diagnosis, Screening & Treatment
  • Epidemiology
    • Table 1: Cancer Statistics For Four Most Common Cancers, 2008
  • Diagnosis
  • Screening
    • Table 2: Cancer Screening
  • Current & Future Treatment
  • Future Treatment
    • Figure 4: Anticancer Drugs In Clinical Development
• Cancer Biomarkers
  • Cancer Biomarker R&d
    • Table 3: Types Of Biomarker
  • Known Cancer Biomarkers
    • Table 4: Commercially Available Known Cancer Biomarker Diagnostics
  • Probable And Possible Valid Cancer Biomarkers
    • Table 5: Probable Cancer Biomarkers Diagnostics
    • Table 6: Possible Cancer Biomarkers Diagnostics
• Cancer Biomarker Opportunities & Challenges
  • Opportunities
  • Challenges
• Biomarker Market
  • Biomarker Market Revenues - Global
    • Figure 8: Global Biomarker Sales In 2007
  • Cancer Biomarker Market Revenues - Global
    • Figure 9: Global Cancer Biomarker Sales In 2007
• • Cancer Biomarkers: Players, Products And Prospects
  • Future Biomarker Market Revenues - Global
    • Figure 10: Global Biomarker Sales In 2015
  • Future Cancer Biomarker Market Revenues - Global
    • Figure 11: Global Cancer Biomarker Sales In 2015
• Cancer Biomarker Trends
  • Table 7: Recent Deals In Oncology Biomarkers
• Pharma And Specialty Pharma Deals
• Collaborations With Service Providers
• Collaborations With Academics And Consortia
• Biomarker Analysis
  • Dna Biomarkers
  • Rna And Microrna Biomarkers
  • Proteomic Biomarkers
• Key Biomarker Companies Analysed
• Key Biomarker Evaluation Criteria
• Cancer Biomarker- Company Analysis
• Abbott Diagnostics
  • Biomarker Novelty & Technology Platform
  • Figure 12: Abbott''s Urovysion Bladder Cancer Test
  • Association Studies/Clinical Data
• Pivotal Trial
  • Table 7: Comparison Of Urovysion Vs Cystoscopy/Histology For Detection Of Bladder Cancer Recurrence By Stage And Grade*
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Affymetrix
  • Biomarker Novelty & Technology Platform
  • Figure 13: Affymetrix'' Approach To Biomarker Discovery, Validation And Clinical Utility Applications
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Agendia Bv
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Figure 14: Mammaprint Profile Vs Nih Consensus Criteria
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Altheadx
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Aveo Pharmaceuticals
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
  • Table Of Contents
  • Cancer Biomarkers: Players, Products And Prospects
• Aviaradx
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Bg Medicine
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Figure 15: Bg Medicines Biomarker Programme
  • Application & Market Potential
  • Biomarker Analysis
• Beckman Coulter
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Biocurex
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Biomedical Diagnostics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Biomerica
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Bruker Daltonics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Caprion Proteomics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Clinical Data
  • Biomarker Novelty & Technology Platform
  • Table Of Contents
• Cancer Biomarkers: Players, Products And Prospects
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Celera
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Dako Denmark A/S
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Dxs Ltd
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Epigenomics Ag
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Epistem Plc
  • Biomarker Novelty & Technology Platform
  • Figure 16: Epistem''s Biomarker Drug Development Programme
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Genenews
  • Biomarker Novelty & Technology Platform
  • Figure 17: Genenews'' Sentinel Principle
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Fujirebio Diagnostics, Inc
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Genomic Health
  • Biomarker Novelty & Technology Platform
  • Figure 18: Oncotype Dx Test For Invasive Breast Cancer
  • Table Of Contents
• Cancer Biomarkers: Players, Products And Prospects
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Gen-Probe
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Genzyme Genetics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Intergenetics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Ipsogen Therapeutics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Figure 19: Oncotype Dx Test For Invasive Breast Cancer
  • Application & Market Potential
  • Biomarker Analysis
• Laboratory Corporation Of America
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Matritech
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Monogram Biosciences
  • Biomarker Novelty & Technology Platform
  • Figure 20: Veratag Assay
  • Association Studies/Clinical Data
  • Figure 21: Veratag Clinical Data: Bordet Cohort
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Orion Genomics
  • Biomarker Novelty & Technology Platform
  • Table Of Contents
• Cancer Biomarkers: Players, Products And Prospects
  • Figure 22: Orion''s Methylscope
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Oxford Genome Biosciences (Uk) Ltd
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Power3 Medical Products
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Figure 23: Powder3''s Business Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Predictive Biosciences
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Provista Life Sciences
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Quest Diagnostics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Roche Diagnostics
  • Biomarker Novelty & Technology Platform
  • Figure 24: Diagnostic Marker Candidate To A Product
  • Association Studies/Clinical Data
  • Figure 25: Biomarkers Distinguish Leukaemia Subclasses
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Superarray Bioscience Corporation
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Third Wave Technologies
  • Table Of Contents
• Cancer Biomarkers: Players, Products And Prospects
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Upstream Biosciences
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Veridex, Llc
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Vermillion
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Cancer Biomarker Appendix 1
  • Table 8: Global Biomarker Sales 2007-20015e
• Cancer Biomarker Appendix 2
  • Table 8: Global Cancer Biomarker Sales 2007-20015e
• Cancer Biomarker Appendix 3
• Company Analysis Criteria
• Biomarker Technology & Platforms
• Association Studies
  • Management Strategy
• Application & Potential
  • Table 9: Key Cancer Biomarker Companies
  • Figure 26: Leading Cancer Biomarker Companies - Service Providers, Technology Providers, Biomarker Discovery & Diagnostic Developers
• Glossary
• Acronyms